<unk>  is a calcitonin gene-related peptide receptor antagonist that is FDA approved for the preventive treatment of migraine in adults.   Common adverse reactions include injection site reactions and constipation.
Erenumab
Alirocumab
Evolocumab
Burosumab
Nebacumab
Sarilumab
Ustekinumab
Avelumab